Abstract
Health-Related Quality of Life in a Biologic Assignment Trial of Reduced Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have